78
45
Growth Score 78 in past quarter
-9 pts
Heat Score 45 in past quarter
-8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
3549924
HemaCare a leading global provider of biological blood products and services since 1978.
Acquired by 

Charles River Laboratories International
- Rochelle Martel: Chief Financial Officer
About the Company
Since 1978, HemaCare Bioresearch Products and Services has been the trusted research partner of choice from concept to commercialization. Built on a 36-year history in apheresis collection, HemaCare is a leader in Cell and Tissue Collection, Processing and Cell Therapy, providing the high-quality biological material derived from normal and
mobilized peripheral blood, bone marrow and cord blood needed to ensure quality research outcomes that meet the unique needs of the scientific community.
